PMDA — authorised 26 September 2022
- Marketing authorisation holder: DAIICHI SANKYO COMPANY, LIMITED
- Status: approved
🇯🇵 Ezharmia in Japan
PMDA authorised Ezharmia on 26 September 2022
Marketing authorisation
Ezharmia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Ezharmia approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Ezharmia in Japan?
DAIICHI SANKYO COMPANY, LIMITED holds the Japanese marketing authorisation.